SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Glaxosmithkline Consumer Healthcare gets shareholders’ nod for merger with HUL

03 Jun 2019 Evaluate

Glaxosmithkline Consumer Healthcare has received approval from its shareholders for merger with Hindustan Unilever (HUL). The company has received 99.99 percent votes in favour of the scheme of amalgamation among the company and HUL in the National Company Law Tribunal-convened meeting of the equity shareholders on June 1, 2019.

Glaxosmithkline Consumer Healthcare’s core business is manufacturing of health drinks under the brand Horlicks.

Glaxo.Cons. Health Share Price

9696.40 0.00 (0.00%)
15-Apr-2020 18:01 View Price Chart
Peers
Company Name CMP
Varun Beverages 474.05
Nestle 1285.65
Britannia Inds 5733.75
LT Foods 422.10
Hatsun Agro Product 979.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×